活血化瘀中药治疗轻中度血管性痴呆的疗效:随机、双盲、平行对照试验

Ming-qing Wei, Jin-zhou Tian, Jing Shi, Fu-yun Ma, Ying-chun Miao, Yong-yan Wang
{"title":"活血化瘀中药治疗轻中度血管性痴呆的疗效:随机、双盲、平行对照试验","authors":"Ming-qing Wei,&nbsp;Jin-zhou Tian,&nbsp;Jing Shi,&nbsp;Fu-yun Ma,&nbsp;Ying-chun Miao,&nbsp;Yong-yan Wang","doi":"10.3736/jcim20121107","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vascular dementia (VaD) is the second common subtype of dementia after Alzheimer's disease. However, there is still a lack of medication that demonstrates clinically relevant symptomatic improvement. Static blood obstructing the brain is the main Chinese medicine syndrome of VaD.</p><p><strong>Objective: </strong>To evaluate the effects of Chinese medicine for promoting blood circulation and removing blood stasis in patients with mild to moderate VaD.</p><p><strong>Design, setting, participants and interventions: </strong>In this 12-week randomized, double-blind, parallel-controlled trial, a total of 48 patients with mild to moderate VaD were enrolled between March 2009 and December 2010. All the patients entered a two-week placebo run-in period followed by a 12-week treatment with Chinese medicine for promoting blood circulation and removing blood stasis (n=24) or placebo (n=24), respectively. The placebo tablets have the identical taste and appearance as the Chinese medicine tablets.</p><p><strong>Main outcome measures: </strong>The primary outcome measure was the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog); the secondary outcome measures included the Activities of Daily Living (ADL) and the Mini-Mental State Examination (MMSE).</p><p><strong>Results: </strong>The Chinese medicine group showed a slight deterioration of 0.25 points and the placebo group showed a deterioration of 2.35 points from baseline by the ADAS-cog, and there was a significant difference between the two groups (P=0.027). The ADL and the MMSE showed no significant difference from baseline in both groups. Adverse events were rare in both groups.</p><p><strong>Conclusion: </strong>The Chinese medicine for promoting blood circulation and removing blood stasis may improve cognition and it is safe and well tolerated.</p>","PeriodicalId":23993,"journal":{"name":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","volume":"10 11","pages":"1240-6"},"PeriodicalIF":0.0000,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.\",\"authors\":\"Ming-qing Wei,&nbsp;Jin-zhou Tian,&nbsp;Jing Shi,&nbsp;Fu-yun Ma,&nbsp;Ying-chun Miao,&nbsp;Yong-yan Wang\",\"doi\":\"10.3736/jcim20121107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Vascular dementia (VaD) is the second common subtype of dementia after Alzheimer's disease. However, there is still a lack of medication that demonstrates clinically relevant symptomatic improvement. Static blood obstructing the brain is the main Chinese medicine syndrome of VaD.</p><p><strong>Objective: </strong>To evaluate the effects of Chinese medicine for promoting blood circulation and removing blood stasis in patients with mild to moderate VaD.</p><p><strong>Design, setting, participants and interventions: </strong>In this 12-week randomized, double-blind, parallel-controlled trial, a total of 48 patients with mild to moderate VaD were enrolled between March 2009 and December 2010. All the patients entered a two-week placebo run-in period followed by a 12-week treatment with Chinese medicine for promoting blood circulation and removing blood stasis (n=24) or placebo (n=24), respectively. The placebo tablets have the identical taste and appearance as the Chinese medicine tablets.</p><p><strong>Main outcome measures: </strong>The primary outcome measure was the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog); the secondary outcome measures included the Activities of Daily Living (ADL) and the Mini-Mental State Examination (MMSE).</p><p><strong>Results: </strong>The Chinese medicine group showed a slight deterioration of 0.25 points and the placebo group showed a deterioration of 2.35 points from baseline by the ADAS-cog, and there was a significant difference between the two groups (P=0.027). The ADL and the MMSE showed no significant difference from baseline in both groups. Adverse events were rare in both groups.</p><p><strong>Conclusion: </strong>The Chinese medicine for promoting blood circulation and removing blood stasis may improve cognition and it is safe and well tolerated.</p>\",\"PeriodicalId\":23993,\"journal\":{\"name\":\"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine\",\"volume\":\"10 11\",\"pages\":\"1240-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3736/jcim20121107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3736/jcim20121107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

摘要

背景:血管性痴呆(VaD)是仅次于阿尔茨海默病的第二常见痴呆亚型。然而,仍然缺乏药物证明临床相关的症状改善。静血阻脑是VaD的主要中医证候。目的:探讨中药活血化瘀对轻、中度VaD患者的治疗作用。设计、环境、参与者和干预措施:在这项为期12周的随机、双盲、平行对照试验中,2009年3月至2010年12月,共有48例轻中度VaD患者入组。所有患者均进入为期两周的安慰剂磨合期,随后分别进行为期12周的活血化瘀中药(n=24)或安慰剂(n=24)治疗。安慰剂片具有与中药片相同的味道和外观。主要结局指标:主要结局指标为阿尔茨海默病评估量表-认知子量表(ADAS-cog);次要结局指标包括日常生活活动(ADL)和简易精神状态检查(MMSE)。结果:中药组ADAS-cog较基线轻度恶化0.25分,安慰剂组较基线轻微恶化2.35分,两组比较差异有统计学意义(P=0.027)。两组患者的ADL和MMSE与基线比较无显著差异。两组的不良事件均罕见。结论:活血化瘀中药具有改善认知的作用,安全性好,耐受性好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.

Background: Vascular dementia (VaD) is the second common subtype of dementia after Alzheimer's disease. However, there is still a lack of medication that demonstrates clinically relevant symptomatic improvement. Static blood obstructing the brain is the main Chinese medicine syndrome of VaD.

Objective: To evaluate the effects of Chinese medicine for promoting blood circulation and removing blood stasis in patients with mild to moderate VaD.

Design, setting, participants and interventions: In this 12-week randomized, double-blind, parallel-controlled trial, a total of 48 patients with mild to moderate VaD were enrolled between March 2009 and December 2010. All the patients entered a two-week placebo run-in period followed by a 12-week treatment with Chinese medicine for promoting blood circulation and removing blood stasis (n=24) or placebo (n=24), respectively. The placebo tablets have the identical taste and appearance as the Chinese medicine tablets.

Main outcome measures: The primary outcome measure was the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog); the secondary outcome measures included the Activities of Daily Living (ADL) and the Mini-Mental State Examination (MMSE).

Results: The Chinese medicine group showed a slight deterioration of 0.25 points and the placebo group showed a deterioration of 2.35 points from baseline by the ADAS-cog, and there was a significant difference between the two groups (P=0.027). The ADL and the MMSE showed no significant difference from baseline in both groups. Adverse events were rare in both groups.

Conclusion: The Chinese medicine for promoting blood circulation and removing blood stasis may improve cognition and it is safe and well tolerated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信